Phase II study of temozolomide as maintenance therapy after disease control of the first-line induction therapy in small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e18557 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e18557-e18557

Author(s):

Haitao Tao ◽

Yi Hu

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Disease Control ◽

Phase Ii ◽

Induction Therapy ◽

Phase Ii Study ◽

Small Cell Lung ◽

Download Full-text

Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study

Medical Oncology ◽

10.1007/s12032-018-1172-x ◽

2018 ◽

Vol 35 (7) ◽

Author(s):

Koji Nishimoto ◽

Masato Karayama ◽

Naoki Inui ◽

Hideki Yasui ◽

Hironao Hozumi ◽

...

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Induction Therapy ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Switch Maintenance Therapy

Download Full-text

Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2218-6 ◽

2013 ◽

Vol 72 (2) ◽

pp. 445-452 ◽

Author(s):

Masato Karayama ◽

Naoki Inui ◽

Shigeki Kuroishi ◽

Koshi Yokomura ◽

Mikio Toyoshima ◽

...

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Induction Therapy ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

A randomized, phase II study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401)

Annals of Oncology ◽

10.1093/annonc/mdz437.046 ◽

2019 ◽

Vol 30 ◽

pp. ix175-ix176

Author(s):

K. Baba ◽

H. Tanaka ◽

Y. Fujita ◽

A. Nakamura ◽

E. Kikuchi ◽

...

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell Lung ◽

Extensive Disease ◽

Randomized Phase Ii

Download Full-text

A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

British Journal of Cancer ◽

10.1038/bjc.2012.555 ◽

2013 ◽

Vol 108 (2) ◽

pp. 265-270 ◽

Author(s):

A Atmaca ◽

S-E Al-Batran ◽

D Werner ◽

C Pauligk ◽

T Güner ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell Lung ◽

Multicentre Phase ◽

First Line Therapy ◽

Download Full-text

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(02)00387-2 ◽

2003 ◽

Vol 39 (1) ◽

pp. 77-84 ◽

Author(s):

J.M Vieitez ◽

M Valladares ◽

M Gracia ◽

M Gonzalez-Barón ◽

G Martı́n ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3092-9 ◽

2016 ◽

Vol 78 (2) ◽

pp. 383-388 ◽

Author(s):

Yusuke Okuma ◽

Yukio Hosomi ◽

Satoshi Takahashi ◽

Yoshiro Nakahara ◽

Kageaki Watanabe ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

Randomised Phase II Study of Axitinib or Bevacizumab Combined with Paclitaxel/Carboplatin (PAC/CARB) as First-Line Therapy for Patients (PTS) with Advanced Non–Small Cell Lung Cancer (NSCLC)

Annals of Oncology ◽

10.1016/s0923-7534(20)33840-0 ◽

2012 ◽

Vol 23 ◽

pp. ix408

Author(s):

C. Twelves ◽

E. Chmielowska ◽

L. Havel ◽

S. Popat ◽

A. Swieboda-Sadlej ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer

European Journal of Cancer ◽

10.1016/s0959-8049(16)30568-8 ◽

2015 ◽

Vol 51 ◽

pp. S196

Author(s):

M. Tamiya ◽

A. Tamiya ◽

H. Kaneda ◽

K. Nakagawa ◽

K. Goto ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Line Chemotherapy

Download Full-text

Phase II Study of Irinotecan Plus Cisplatin as First Line therapy in Extensive Small-Cell Lung Cancer

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2006.61.2.143 ◽

2006 ◽

Vol 61 (2) ◽

pp. 143

Author(s):

Ki Eun Hwang ◽

So Young Kim ◽

Jong Hoon Jung ◽

Seong Hoon Park ◽

Jung Hyun Park ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70413-5 ◽

2007 ◽

Vol 2007 ◽

pp. 195-197

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Single Agent ◽

Small Cell Lung ◽

Agent Treatment

Download Full-text